Corinne Reimer

3.7k total citations
52 papers, 2.1k citations indexed

About

Corinne Reimer is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Corinne Reimer has authored 52 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 16 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Corinne Reimer's work include Ubiquitin and proteasome pathways (6 papers), Angiogenesis and VEGF in Cancer (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Corinne Reimer is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Angiogenesis and VEGF in Cancer (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Corinne Reimer collaborates with scholars based in United States, United Kingdom and Canada. Corinne Reimer's co-authors include Sam W. Lee, Phil Oh, Jan E. Schnitzer, Stuart A. Aaronson, Siavash K. Kurdistani, Raghu Kalluri, Surender Kharbanda, Bruce J. Crawford, Mark Manfredi and Yohei Maeshima and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Molecular and Cellular Biology.

In The Last Decade

Corinne Reimer

49 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Corinne Reimer United States	23	1.4k	460	456	441	254	52	2.1k
Emma T. Bowden United States	17	1.1k 0.8×	619 1.3×	407 0.9×	319 0.7×	330 1.3×	25	1.8k
Bruce E. Elliott Canada	26	1.1k 0.8×	298 0.6×	584 1.3×	295 0.7×	294 1.2×	62	1.9k
Kiyoko Yoshioka Japan	23	1.6k 1.1×	626 1.4×	693 1.5×	339 0.8×	278 1.1×	38	2.4k
Johan Dixelius Sweden	16	1.5k 1.1×	207 0.5×	458 1.0×	562 1.3×	315 1.2×	18	2.1k
Eva Grönroos United Kingdom	21	1.5k 1.1×	393 0.9×	571 1.3×	466 1.1×	171 0.7×	29	2.2k
Bernd Hinzmann Germany	24	1.7k 1.2×	331 0.7×	808 1.8×	958 2.2×	220 0.9×	47	3.0k
Radha P. Narsimhan United States	16	1.9k 1.3×	278 0.6×	646 1.4×	305 0.7×	111 0.4×	20	3.1k
Richard A. Klinghoffer United States	18	1.7k 1.2×	646 1.4×	418 0.9×	234 0.5×	441 1.7×	31	2.5k
Christel Moog‐Lutz France	23	1.3k 1.0×	327 0.7×	409 0.9×	424 1.0×	183 0.7×	32	2.0k
Farzan Rastinejad United States	13	2.2k 1.6×	280 0.6×	1.0k 2.2×	732 1.7×	229 0.9×	13	2.9k

Countries citing papers authored by Corinne Reimer

Since Specialization

Citations

This map shows the geographic impact of Corinne Reimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corinne Reimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corinne Reimer more than expected).

Fields of papers citing papers by Corinne Reimer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corinne Reimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corinne Reimer. The network helps show where Corinne Reimer may publish in the future.

Co-authorship network of co-authors of Corinne Reimer

This figure shows the co-authorship network connecting the top 25 collaborators of Corinne Reimer. A scholar is included among the top collaborators of Corinne Reimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corinne Reimer. Corinne Reimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Willis, Brandon S., Hannah Dry, Wendan Xu, et al.. (2024). Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma. Leukemia. 38(12). 2663–2674. 2 indexed citations

Wen, Shenghua, Graeme Scarfe, Justin Cidado, et al.. (2023). A PKPD Case Study: Achieving Clinically Relevant Exposures of AZD5991 in Oncology Mouse Models. The AAPS Journal. 25(4). 66–66. 1 indexed citations

Young, Lucy A., Christelle de Renty, Margaret H. Veldman-Jones, et al.. (2019). Differential Activity of ATR and WEE1 Inhibitors in a Highly Sensitive Subpopulation of DLBCL Linked to Replication Stress. Cancer Research. 79(14). 3762–3775. 54 indexed citations

Zhang, Jingwen, Austin Dulak, Maureen M. Hattersley, et al.. (2018). BRD4 facilitates replication stress-induced DNA damage response. Oncogene. 37(28). 3763–3777. 67 indexed citations

Borodovsky, Alexandra, Yanjun Wang, Minwei Ye, et al.. (2017). Abstract 5580: Preclinical pharmacodynamics and antitumor activity of AZD4635, a novel adenosine 2A receptor inhibitor that reverses adenosine mediated T cell suppression. Cancer Research. 77(13_Supplement). 5580–5580. 19 indexed citations

Schuller, Alwin G., Evan Barry, Rhys D.O. Jones, et al.. (2015). The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) Induces Regression in Papillary Renal Cell Carcinoma Patient–Derived Xenograft Models. Clinical Cancer Research. 21(12). 2811–2819. 57 indexed citations

Laing, Naomi, Shenghua Wen, David C.H. Yang, et al.. (2013). Inhibition of Platelet-Derived Growth Factor Receptor α by MEDI-575 Reduces Tumor Growth and Stromal Fibroblast Content in a Model of Non-Small Cell Lung Cancer. Molecular Pharmacology. 83(6). 1247–1256. 14 indexed citations

Loveless, Mary E., Deborah Lawson, Michael P. Collins, et al.. (2012). Comparisons of the Efficacy of a Jak1/2 Inhibitor (AZD1480) with a VEGF Signaling Inhibitor (Cediranib) and Sham Treatments in Mouse Tumors Using DCE-MRI, DW-MRI, and Histology. Neoplasia. 14(1). 54–64. 36 indexed citations

Brown, Jeffrey L., Zhe Cao, Maria Pinzon-Ortiz, et al.. (2010). A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models. Molecular Cancer Therapeutics. 9(1). 145–156. 113 indexed citations

10.

Williamson, Mark J., Jonathan L. Blank, Frank J. Bruzzese, et al.. (2006). Comparison of biochemical and biological effects of ML858 (salinosporamide A) and bortezomib. Molecular Cancer Therapeutics. 5(12). 3052–3061. 57 indexed citations

11.

Zhang, Yumin, Matthew D. Silva, Mark Rolfe, et al.. (2006). Longitudinally Quantitative 2-Deoxy-2-[18F]fluoro-d-glucose Micro Positron Emission Tomography Imaging for Efficacy of New Anticancer Drugs: A Case Study with Bortezomib in Prostate Cancer Murine Model. Molecular Imaging and Biology. 8(5). 300–308. 14 indexed citations

12.

Singh, Purva, Corinne Reimer, John H. Peters, et al.. (2004). The Spatial and Temporal Expression Patterns of Integrin α9β1 and One of Its Ligands, the EIIIA Segment of Fibronectin, in Cutaneous Wound Healing. Journal of Investigative Dermatology. 123(6). 1176–1181. 78 indexed citations

13.

Maeshima, Yohei, Udaya Yerramalla, Mohanraj Dhanabal, et al.. (2001). Extracellular Matrix-derived Peptide Binds to αvβ3 Integrin and Inhibits Angiogenesis. Journal of Biological Chemistry. 276(34). 31959–31968. 174 indexed citations

14.

Maeshima, Yohei, Mark Manfredi, Corinne Reimer, et al.. (2001). Identification of the Anti-angiogenic Site within Vascular Basement Membrane-derived Tumstatin. Journal of Biological Chemistry. 276(18). 15240–15248. 179 indexed citations

15.

Andree, Christoph, et al.. (2001). Basement Membrane Formation during Wound Healing Is Dependent on Epidermal Transplants. Plastic & Reconstructive Surgery. 107(1). 97–104. 14 indexed citations

16.

Kurdistani, Siavash K., et al.. (1998). Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage.. PubMed. 58(19). 4439–44. 225 indexed citations

17.

Lee, Sam W., et al.. (1998). Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene. 16(11). 1391–1397. 375 indexed citations

18.

Crawford, Bruce J., et al.. (1997). Ultrastructure and synthesis of the extracellular matrix ofPisaster ochraceus embryos preserved by freeze substitution. Journal of Morphology. 232(2). 133–153. 14 indexed citations

19.

Reimer, Corinne & Bruce J. Crawford. (1997). Isolation and characterization of an endodermally derived, proteoglycan‐like extracellular matrix molecule that may be involved in larval starfish digestive tract morphogenesis. Development Growth & Differentiation. 39(3). 381–397. 7 indexed citations

20.

Reid, P. E., et al.. (1989). The histochemical specificity of High Iron Diamine—Alcian Blue. The Histochemical Journal. 21(8). 501–507. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact